The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

REFILE-Indivior quarterly profit slumps, sets full-year revenue target

Thu, 29th Oct 2020 11:20

(Refiles to remove dollar signs, figures are in pounds)

Oct 29 (Reuters) - British drugmaker Indivior Plc
reported a near 70% slump in third-quarter profit on Thursday
and said it expects full-year net revenue between a range of
$595 million to $620 million.

The company, which makes opioid addiction treatments, said
operating profit in the quarter ended Sept. 30 fell to 18
million pounds from 57 million pounds a year ago.

Indivior said it saw a modest improvement in new patient
enrollments in the quarter compared to a rapid decline in the
second quarter due to COVID-19 related disruptions.
(Reporting by Aakash Jagadeesh Babu in Bengaluru)

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.